ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
12/01/2025
Back to search
Official data from USPTO
GQ
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
12/02/2025
Trademark type
Word
Nice classes
5, 40, 42
Filing date
10/11/2022
Registration date
08/06/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/06/2024
Last transaction
12/02/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
27
Owner location
HAMBURG, DE
Examiner
BACZESKI,LILLIANNA M
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
PACIRA GERMANY GMBH
GQ BIO THERAPEUTICS GMBH
GeneQuine Biotherapeutics GmbH
Representatives
Keith Toms, Esq. McCarter & English, LLP
Technical classification
Nice Classes
Class 5Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Vaccines; Analgesic preparations; Anti-arthritic compositions and preparations; Anti-cancer preparations; Anti-inflammatory preparations; Biological preparations for the treatment of cancer; Biological preparations for the treatment of musculoskeletalgeneticmetabolicendocrinecardiovascularcardiopulmonarygenitourinaryoncologicalhepatologicalnephrologicalhematologicalophthalmicrespiratoryneurologicalgastrointestinalhormonalinfectiousdermatologicalimmune system related diseases and disorders; Biological tissue cultures for medical purposes; Biological tissue cultures for veterinary purposes; Biological skin tissuesliver tissuesjoint tissuesbonecartilagesynoviumtendon tissuesall intended for subsequent implantation; Cells for medical or clinical use; Diagnostic agentspreparations and substances for medical purposes; Diagnostic preparations for medical or veterinary purposes; Drug testing kits comprised of medical diagnostic reagents and assays for testing body fluids; Gene therapy productsgenetically engineered tissues for transplant purposes; Human vaccine preparations; Medicaments for promoting recovery from tendon and muscle injuries and disorders and sports related injuries; Nucleic acid sequences and chemical reagents for medical and veterinary purposes; Pain relief medication; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations for the treatment and prevention of musculoskeletalgeneticmetabolicendocrinecardiovascularcerebrovascularcardiopulmonarygenitourinaryoncologicalhepatologicalnephrologicalhematologicalophthalmicrespiratoryneurologicalgastrointestinalhormonalinfectiousdermatologicalimmune system related diseases and disorders; Veterinary pharmaceutical preparations for the prevention of musculoskeletalgeneticmetabolicendocrinecardiovascularpulmonarygenitourinaryoncologicalhepatologicalhematologicalophthalmicrespiratoryneurologicalgastrointestinalhormonalinfectiousdermatologicalimmune system related diseases and disorders; Veterinary pharmaceutical preparations for the treatment of musculoskeletalgeneticmetabolicendocrinecardiovascularpulmonarygenitourinaryoncologicalhepatologicalhematologicalophthalmicrespiratoryneurologicalgastrointestinalhormonalinfectiousdermatologicalimmune system related diseases and disorders; Veterinary preparationspain relief medication; Veterinary vaccines; In vitro diagnostic preparations for medical use
Class 40
Biomanufacturing for othersmanufacturing of biologicsvaccinesnon-viral and viral vectorsgene and cell therapy preparationsall using biological organisms in the manufacturing process; Custom manufacture of pharmaceuticalsbiologicsvaccinesbiotechnological productsnon-viral and viral vectorsgene and cell therapy preparations by pharmaceutical compounders; Custom manufacture of pharmaceuticalsbiologicsvaccinesbiotechnological medicationsnon-viral and viral vectorsgene and cell therapy preparations; Manufacturing process consulting; Manufacturing services for others in the field of pharmaceuticalsbiologicsvaccinesnon-viral and viral vectorsgene therapy and gene and cell therapy preparations; Technical support servicesproviding technical advice related to the manufacture of biologicsgene therapy preparationsvaccinesnon-viral and viral vectors
Class 42
Consulting services in the field of pharmaceutical research and development; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Research and development in the field of geneticsgene therapycell therapyvaccinesbiotechnological productionnon-viral and viral vector production; Pharmaceutical drug development services for prevention and treatment of musculoskeletalgeneticophthalmicmetabolicendocrinecardiovascularcerebrovascularcardiopulmonarygenitourinaryoncologicalhepatologicalnephrologicalhematologicalrespiratoryneurologicalgastrointestinalhormonalinfectiousdermatologicalimmune system related diseases and disorders; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines; Scientific research and development; Scientific research consulting in the field of geneticsgene therapycell therapyvaccinesbiotechnological productionnon-viral and viral vector production; Scientific research for medical purposes in the field of musculoskeletalgeneticmetabolicendocrinecardiovascularcerebrovascularcardiopulmonarygenitourinaryoncologicalhepatologicalnephrologicalhematologicalophthalmicrespiratoryneurologicalgastrointestinalhormonalinfectiousdermatologicalimmune system related diseases and disorders; Scientific research in the field of genetics and genetic engineering; Testinginspectionresearchdevelopment of pharmaceutical preparations for gene therapy
Publications
History of USPTO decisions and trademark events.
33 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/01/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/01/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/01/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/20/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
08/20/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/20/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/20/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/20/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/20/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/06/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
08/06/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/21/2024
PUBO
PUBLISHED FOR OPPOSITION
05/21/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/01/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/15/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/11/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/11/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/11/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/21/2024
GNRT
NON-FINAL ACTION E-MAILED
02/21/2024
CNRT
NON-FINAL ACTION WRITTEN
02/21/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/22/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/22/2024
ALIE
ASSIGNED TO LIE
01/22/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/31/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/23/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/14/2023
GNRT
NON-FINAL ACTION E-MAILED
08/14/2023
CNRT
NON-FINAL ACTION WRITTEN
08/14/2023
DOCK
ASSIGNED TO EXAMINER
07/26/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/26/2022
NWAP
NEW APPLICATION ENTERED
10/14/2022
Continuous trademark protection
Get notified about every new filing that threatens GQ or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.